What estimate do you have for expenses in FY24?
Just be cognisant that the company's guidance commentary is as follows: "Operating expenditure will increase to support the expansion of USA commercial infrastructure with the underlying operating results for the glaucoma surgical segment expected to improve progressively during the year ending 30 June 2024.”
That sounds to me like total opex is still on the way up, albeit divisional opex may fall over time.
Nova Eye Medical (EYE) Discussion, page-786
-
- There are more pages in this discussion • 2,402 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $24.11K | 132.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 137086 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 30000 | 1 |
View Market Depth
| Last trade - 14.41pm 04/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |